External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

<ul><li>Akebia Therapeutics aims to challenge the standard of care for anemia management in chronic kidney disease in the USA</li><li>Despite setbacks with FDA rejection of new drug Vafseo, company holds growth potential</li><li>Aims to have over 75,000 patients prescribed to Vafseo by end of 2026, leading to significant sales growth and operating profit; stock seen as undervalued with potential to reach price target of $5.00+</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Akebia Therapeutics aims to challenge the standard of care for anemia management in chronic kidney disease in the USADespite setbacks with FDA rejection of new drug Vafseo, company holds growth potentialAims to have over 75,000 patients prescribed to Vafseo by end of 2026, leading to significant sales growth and operating profit; stock seen as undervalued with potential to reach price target of $5.00+This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Akebia Therapeutics Inc (AKBA) - Friday, Oct 25, 2024